8.17  0.5 (6.52%)		08-18 16:00
Open: 7.71 High: 8.27 Volume: 1,986,196		Pre. Close: 7.67 Low: 7.71 Market Cap: 641(M)

Short term
Mid term
Targets	6-month :	10.48	1-year :	12.25
Resists	First :	8.97	Second :	10.48
Pivot price	7.53
Supports	First :	7.81	Second :	7.09
MAs	MA(5) :	7.72	MA(20) :	7.59
	MA(100) :	7.86	MA(250) :	9.14
MACD	MACD :	-0.1	Signal :	-0.2
%K %D	K(14,3) :	36.8	D(3) :	33.1
RSI	RSI(14): 55.8
52-week	High :	14.96	Low :	6.13

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CRMD ] has closed Bollinger Bands are 3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	8.28 - 8.31	8.31 - 8.35
Low:	7.63 - 7.67	7.67 - 7.7
Close:	8.11 - 8.17	8.17 - 8.22

CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.

Tue, 18 Aug 2026
CorMedix: Durable Commercial Base, But 2027 Is The Real Test (NASDAQ:CRMD) - Seeking Alpha

Mon, 17 Aug 2026
CorMedix Inc (NASDAQ: CRMD) Share Price, CRMD Stock News, CRMD Share Price & Updates - Kalkine

Mon, 17 Aug 2026
CorMedix (NASDAQ:CRMD) Shares Up 7.3% on Analyst Upgrade - MarketBeat

Sat, 15 Aug 2026
CorMedix Inc (CRMD) Stock News Today - TradingKey

Fri, 14 Aug 2026
CRMD Stock Up as Q2 Earnings & Sales Beat on DefenCath, Melinta Gains - TradingView

Fri, 14 Aug 2026
CRMD News | CORMEDIX INC (NASDAQ:CRMD) - ChartMill

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	78 (M)
Shares Float	67 (M)
Held by Insiders	7.5 (%)
Held by Institutions	54.8 (%)
Shares Short	15,350 (K)
Shares Short P.Month	14,510 (K)

EPS	2.17
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	5.57
Profit Margin	45.2 %
Operating Margin	49.9 %
Return on Assets (ttm)	26.3 %
Return on Equity (ttm)	65.5 %
Qtrly Rev. Growth	226.1 %
Gross Profit (p.s.)	4.68
Sales Per Share	5.09
EBITDA (p.s.)	2.91
Qtrly Earnings Growth	42.7 %
Operating Cash Flow	198 (M)
Levered Free Cash Flow	120 (M)

PE Ratio	3.76
PEG Ratio	0
Price to Book value	1.46
Price to Sales	1.6
Price to Cash Flow	3.24

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.